Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Alejandro A Gutiérrez-Hernández

Autonomous University, Mexico

Title: In silico evaluation of SNPs at the interface of ACE2 forming the ligandreceptor complex with the Spike protein

Biography

Biography: Alejandro A Gutiérrez-Hernández

Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has recently emerged in China and caused the disease COVID-19, the virus spread rapidly around the world, causing a global outbreak. Protein-protein binding assays have confirmed that Angiotensin-Converting Enzyme 2 (ACE2) is the cellular receptor through which the virus invades the host cell. The severity of the symptoms and the rapid progression of the disease have led to in-depth investigation of this virus, suggesting a response by which some populations are more susceptible to the entry of the SARS-CoV-2 virus and this may be due to polymorphisms of a Single Nucleotide (SNP) present in various populations in this case in the ACE2 receptor. In this study, nsSNPs present in the ACE2 interface were selected, the amino acid changes corresponding to each nsSNP were made from the base model that form the ACE2-SARS- CoV-2 complex, the binding energy and the binding constant were calculated. protein-protein interaction dissociation. The results of the analysis indicate that the presence of the Asp355Asn and Ser19Pro variants in ACE2 decrease the binding affinity in the protein-protein complex, therefore, we suggest a lower susceptibility to COVID-19 disease. However, the Glu329Gly and Glu37Lys variants indicate an increase in binding affinity according to the physicochemical parameters evaluated, so their presence in ACE2 would possibly increase susceptibility to COVID-19 disease.